Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
Antimicrob Agents Chemother
    May 2023
  1. XU J, Li D, Shi J, Wang B, et al
    Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
    Antimicrob Agents Chemother. 2023 May 31:e0153222. doi: 10.1128/aac.01532.
    >> Share

  2. NELSON-RIGG R, Fagan SP, Jaremko WJ, Pata JD, et al
    Pre-Steady-State Kinetic Characterization of an Antibiotic-Resistant Mutant of Staphylococcus aureus DNA Polymerase PolC.
    Antimicrob Agents Chemother. 2023 May 24:e0157122. doi: 10.1128/aac.01571.
    >> Share

  3. MORRISETTE T, Stamper KC, Lev KL, Kebriaei R, et al
    Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model.
    Antimicrob Agents Chemother. 2023 May 24:e0131722. doi: 10.1128/aac.01317.
    >> Share

  4. KORDALEWSKA M, Cancino-Prado G, Nobrega de Almeida Junior J, Brasil Brandao I, et al
    Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance.
    Antimicrob Agents Chemother. 2023 May 24:e0042323. doi: 10.1128/aac.00423.
    >> Share

  5. DAWSON R, Diacon AH, Narunsky K, De Jager VR, et al
    Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832.
    Antimicrob Agents Chemother. 2023 May 23:e0147722. doi: 10.1128/aac.01477.
    >> Share

  6. JAKIELASZEK C, Hilliard JJ, Mannino F, Hossain M, et al
    Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge.
    Antimicrob Agents Chemother. 2023;67:e0138122.
    >> Share

  7. MASON CS, Avis T, Hu C, Nagalingam N, et al
    The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic.
    Antimicrob Agents Chemother. 2023;67:e0156322.
    >> Share

  8. HU X, Dong R, Huang S, Zeng Y, et al
    CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models.
    Antimicrob Agents Chemother. 2023;67:e0170422.
    >> Share

  9. KOCER K, Boudour-Halil D, Chanthalangsy Q, Sahr A, et al
    Genomic Modification of TonB and Emergence of Small-Colony Phenotype in VIM- and NDM-Producing Escherichia coli following Cefiderocol Exposure In Vitro.
    Antimicrob Agents Chemother. 2023;67:e0011823.
    >> Share

  10. YETMAR ZA, Chesdachai S, Lahr BD, Challener DW, et al
    Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis.
    Antimicrob Agents Chemother. 2023 May 16:e0012023. doi: 10.1128/aac.00120.
    >> Share

  11. XU L, Henriksen C, Mebus V, Guerillot R, et al
    A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology.
    Antimicrob Agents Chemother. 2023 May 15:e0032823. doi: 10.1128/aac.00328.
    >> Share

  12. JOHN LLH, Thomson DD, Bicanic T, Hoenigl M, et al
    Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris In Vitro.
    Antimicrob Agents Chemother. 2023 May 10:e0164522. doi: 10.1128/aac.01645.
    >> Share

  13. SINGH NV, Singh KV, Dinh AQ, Arias CA, et al
    Colocalization of Linezolid Resistance (cfr) and Virulence Factors Cytolysin and Hemolysin (cln and hln) on a Plasmid in Enterococcus faecalis.
    Antimicrob Agents Chemother. 2023 May 10:e0025923. doi: 10.1128/aac.00259.
    >> Share

  14. MATHIYAZAKAN V, Wong CF, Harikishore A, Pethe K, et al
    Cryo-Electron Microscopy Structure of the Mycobacterium tuberculosis Cytochrome bcc:aa(3) Supercomplex and a Novel Inhibitor Targeting Subunit Cytochrome cI.
    Antimicrob Agents Chemother. 2023 May 9:e0153122. doi: 10.1128/aac.01531.
    >> Share

  15. DAFFINEE KE, Piehl EC, Bleick C, LaPlante KL, et al
    Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
    Antimicrob Agents Chemother. 2023 May 8:e0010823. doi: 10.1128/aac.00108.
    >> Share

    April 2023
  16. STONE MC, Mychack A, Coe KA, Walker S, et al
    Combining Signal Peptidase and Lipoprotein Processing Inhibitors Overcomes Ayr Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2023 Apr 25:e0011523. doi: 10.1128/aac.00115.
    >> Share

  17. ZHU Y, Zhu L, Davies Forsman L, Paues J, et al
    Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens.
    Antimicrob Agents Chemother. 2023 Apr 25:e0170022. doi: 10.1128/aac.01700.
    >> Share

  18. BEATTIE SR, Esan T, Zarnowski R, Eix E, et al
    Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of In Vivo Candida albicans Vascular Catheter Infection and Ex Vivo Candida auris Skin Colonization.
    Antimicrob Agents Chemother. 2023 Apr 25:e0008123. doi: 10.1128/aac.00081.
    >> Share

  19. SOBEL JD
    Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center.
    Antimicrob Agents Chemother. 2023 Apr 24:e0018123. doi: 10.1128/aac.00181.
    >> Share

  20. ELGAMMAL Y, Salama EA, Seleem MN
    Atazanavir Resensitizes Candida auris to Azoles.
    Antimicrob Agents Chemother. 2023 Apr 24:e0163122. doi: 10.1128/aac.01631.
    >> Share

  21. WOOD GE, Kim CM, Aguila LKT, Cichewicz RH, et al
    In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles.
    Antimicrob Agents Chemother. 2023;67:e0000623.
    >> Share

  22. RODRIGUEZ R, Campbell-Kruger N, Gonzalez Camba J, Berude J, et al
    MarR-Dependent Transcriptional Regulation of mmpSL5 Induces Ethionamide Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2023;67:e0135022.
    >> Share

  23. HODGES MR, Ople E, Wedel P, Shaw KJ, et al
    Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers.
    Antimicrob Agents Chemother. 2023;67:e0162322.
    >> Share

  24. WANG C, Sun Z, Hu Y, Li D, et al
    A Novel Anti-CRISPR AcrIE9.2 Is Associated with Dissemination of bla(KPC) Plasmids in Klebsiella pneumoniae Sequence Type 15.
    Antimicrob Agents Chemother. 2023;67:e0154722.
    >> Share

  25. HUANG Y, Wu Y, Cai C, Zhang R, et al
    Phenotypic and Genomic Characterization of ST133 Siderophore-Encoding Extensively Drug-Resistant Enterobacter hormaechei.
    Antimicrob Agents Chemother. 2023;67:e0173722.
    >> Share

  26. NEGATU DA, Aragaw WW, Cangialosi J, Dartois V, et al
    Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections.
    Antimicrob Agents Chemother. 2023;67:e0165522.
    >> Share

  27. D'ANGELO F, Rocha EPC, Rendueles O
    The Capsule Increases Susceptibility to Last-Resort Polymyxins, but Not to Other Antibiotics, in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2023;67:e0012723.
    >> Share

  28. LIU Y, Moodley M, Pasipanodya JG, Gumbo T, et al
    Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments.
    Antimicrob Agents Chemother. 2023;67:e0140122.
    >> Share

  29. ARMENGOL E, Kragh KN, Tolker-Nielsen T, Sierra JM, et al
    Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.
    Antimicrob Agents Chemother. 2023;67:e0164122.
    >> Share

  30. TANG B, Yang A, Liu P, Wang Z, et al
    Outer Membrane Vesicles Transmitting bla(NDM-1) Mediate the Emergence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2023 Apr 13:e0144422. doi: 10.1128/aac.01444.
    >> Share

  31. VAZQUEZ JA, Pappas PG, Boffard K, Paruk F, et al
    Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial.
    Antimicrob Agents Chemother. 2023 Apr 6:e0141922. doi: 10.1128/aac.01419.
    >> Share

    March 2023
  32. KHATEB A, Gago S, Bromley M, Richardson M, et al
    Aneuploidy Is Associated with Azole Resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2023 Mar 28:e0125322. doi: 10.1128/aac.01253.
    >> Share

  33. ECKHARDT E, Li Y, Mamerow S, Schinkothe J, et al
    Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model.
    Antimicrob Agents Chemother. 2023 Mar 28:e0143822. doi: 10.1128/aac.01438.
    >> Share

  34. HASHIMOTO Y, Suzuki M, Kobayashi S, Hirahara Y, et al
    Enterococcal Linear Plasmids Adapt to Enterococcus faecium and Spread within Multidrug-Resistant Clades.
    Antimicrob Agents Chemother. 2023 Mar 28:e0161922. doi: 10.1128/aac.01619.
    >> Share

  35. LI D, Ge Y, Wang N, Shi Y, et al
    Identification and Characterization of a Novel Major Facilitator Superfamily Efflux Pump, SA09310, Mediating Tetracycline Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2023 Mar 23:e0169622. doi: 10.1128/aac.01696.
    >> Share

  36. BHAVNANI SM, Hammel JP, Lakota EA, Trang M, et al
    Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
    Antimicrob Agents Chemother. 2023 Mar 22:e0221321. doi: 10.1128/aac.02213.
    >> Share

  37. SLARVE M, Reyna Z, Burk E, Ruiz-Delgado J, et al
    Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2023;67:e0008623.
    >> Share

  38. HALLAL FERREIRA RARO O, Nordmann P, Dominguez Pino M, Findlay J, et al
    Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.
    Antimicrob Agents Chemother. 2023;67:e0142422.
    >> Share

  39. DE JESUS DFF, De Freitas ALD, De Oliveira IM, De Almeida LC, et al
    Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors.
    Antimicrob Agents Chemother. 2023;67:e0075922.
    >> Share

  40. ZHANG P, Hu H, Shi Q, Sun L, et al
    The Effect of beta-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2023;67:e0127922.
    >> Share

  41. HIRAYAMA T, Miyazaki T, Sumiyoshi M, Ito Y, et al
    Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations.
    Antimicrob Agents Chemother. 2023 Mar 15:e0124322. doi: 10.1128/aac.01243.
    >> Share

  42. LI SY, Converse PJ, Betoudji F, Lee J, et al
    Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model.
    Antimicrob Agents Chemother. 2023 Mar 15:e0003523. doi: 10.1128/aac.00035.
    >> Share

  43. ISMAIL N, Dippenaar A, Warren RM, Peters RPH, et al
    Emergence of Canonical and Noncanonical Genomic Variants following In Vitro Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine.
    Antimicrob Agents Chemother. 2023 Mar 9:e0136822. doi: 10.1128/aac.01368.
    >> Share

  44. IMBERT S, Normand AC, Costa D, Gabriel F, et al
    Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Clinical Isolates from Aspergillus Section Circumdati.
    Antimicrob Agents Chemother. 2023 Mar 9:e0146222. doi: 10.1128/aac.01462.
    >> Share

  45. CABELLOS C, Guillem L, Pelegrin I, Tubau F, et al
    Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone".
    Antimicrob Agents Chemother. 2023 Mar 7:e0005023. doi: 10.1128/aac.00050.
    >> Share

  46. LE TURNIER P, Tattevin P, Varon E, Duval X, et al
    Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
    Antimicrob Agents Chemother. 2023 Mar 7:e0001223. doi: 10.1128/aac.00012.
    >> Share

  47. MISHRA NN, Abdelhady W, Elsayed AM, Lapitan C, et al
    Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resist
    Antimicrob Agents Chemother. 2023 Mar 6:e0147222. doi: 10.1128/aac.01472.
    >> Share

  48. ARENDS SJR, Butler D, Scangarella-Oman N, Castanheira M, et al
    Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
    Antimicrob Agents Chemother. 2023 Mar 6:e0152522. doi: 10.1128/aac.01525.
    >> Share

    February 2023
  49. PRESENTE S, Bonnal C, Normand AC, Gaudonnet Y, et al
    Hospital Clonal Outbreak of Fluconazole-Resistant Candida parapsilosis Harboring the Y132F ERG11p Substitution in a French Intensive Care Unit.
    Antimicrob Agents Chemother. 2023 Feb 28:e0113022. doi: 10.1128/aac.01130.
    >> Share

  50. LOHSEN S, Stephens DS
    Inducible Mega-Mediated Macrolide Resistance Confers Heteroresistance in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2023 Feb 27:e0131922. doi: 10.1128/aac.01319.
    >> Share

  51. ABDELGAWAD N, Tshavhungwe MP, Rohlwink U, McIlleron H, et al
    Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis.
    Antimicrob Agents Chemother. 2023 Feb 23:e0147422. doi: 10.1128/aac.01474.
    >> Share

  52. TASCINI C, Antonelli A, Pini M, De Vivo S, et al
    Infective Endocarditis Associated with Implantable Cardiac Device by Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa, Successfully Treated with Source Control and Cefiderocol Plus Imipenem.
    Antimicrob Agents Chemother. 2023 Feb 23:e0131322. doi: 10.1128/aac.01313.
    >> Share

  53. LEDGER EVK, Lau K, Tate EW, Edwards AM, et al
    XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2023 Feb 21:e0120622. doi: 10.1128/aac.01206.
    >> Share

  54. CABOT G, Kim K, Mark BL, Oliver A, et al
    Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2023;67:e0140922.
    >> Share

  55. NEGATU DA, Gonzalez Del Rio R, Cacho-Izquierdo M, Barros-Aguirre D, et al
    Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.
    Antimicrob Agents Chemother. 2023;67:e0145922.
    >> Share

  56. GARCIA A, Huh EY, Lee SC
    Serine/Threonine Phosphatase Calcineurin Orchestrates the Intrinsic Resistance to Micafungin in the Human-Pathogenic Fungus Mucor circinelloides.
    Antimicrob Agents Chemother. 2023;67:e0068622.
    >> Share

  57. KUNKEL M, Doyle-Eisele M, Kuehl P, Rotermund K, et al
    Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection.
    Antimicrob Agents Chemother. 2023;67:e0114422.
    >> Share

  58. LONG J, Zhang J, Xi Y, Zhao J, et al
    Genomic Insights into CRISPR-Harboring Plasmids in the Klebsiella Genus: Distribution, Backbone Structures, Antibiotic Resistance, and Virulence Determinant Profiles.
    Antimicrob Agents Chemother. 2023 Feb 15:e0118922. doi: 10.1128/aac.01189.
    >> Share

  59. ALMEIDA DV, Converse PJ, Nuermberger EL
    Mutations in Rv0678 Reduce Susceptibility of Mycobacterium tuberculosis to the DprE1 Inhibitor TBA-7371.
    Antimicrob Agents Chemother. 2023 Feb 14:e0005223. doi: 10.1128/aac.00052.
    >> Share

  60. BONN CM, Rafiqullah IM, Crawford JA, Qian YM, et al
    Repeated Emergence of Variant TetR Family Regulator, FarR, and Increased Resistance to Antimicrobial Unsaturated Fatty Acid among Clonal Complex 5 Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2023 Feb 6:e0074922. doi: 10.1128/aac.00749.
    >> Share

  61. CHIREHWA MT, Resendiz-Galvan JE, Court R, De Kock M, et al
    Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling.
    Antimicrob Agents Chemother. 2023 Feb 6:e0142622. doi: 10.1128/aac.01426.
    >> Share

    January 2023
  62. CUSUMANO JA, Daffinee KE, Ugalde-Silva P, Peti W, et al
    Penicillin-Binding Proteins and Alternative Dual-Beta-Lactam Combinations for Serious Enterococcus faecalis Infections with Elevated Penicillin MICs.
    Antimicrob Agents Chemother. 2023 Jan 31:e0087122. doi: 10.1128/aac.00871.
    >> Share

  63. JIMENEZ-TORO I, Rodriguez CA, Zuluaga AF, Otalvaro JD, et al
    Pharmacokinetic/Pharmacodynamic Index Linked to In Vivo Efficacy of the Ampicillin-Ceftriaxone Combination against Enterococcus faecalis.
    Antimicrob Agents Chemother. 2023 Jan 25:e0096622. doi: 10.1128/aac.00966.
    >> Share

  64. SHEWELL LK, Day CJ, De Bisscop X, Edwards JL, et al
    Repurposing Carbamazepine To Treat Gonococcal Infection in Women: Oral Delivery for Control of Epilepsy Generates Therapeutically Effective Levels in Vaginal Secretions.
    Antimicrob Agents Chemother. 2023;67:e0096822.
    >> Share

  65. TRANG M, Hammel JP, Lakota EA, Safir MC, et al
    Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia.
    Antimicrob Agents Chemother. 2023;67:e0220121.
    >> Share

  66. ZEISER ET, Becka SA, LiPuma JJ, Papp-Wallace KM, et al
    Activity of ETX0462 toward Some Burkholderia spp.
    Antimicrob Agents Chemother. 2023;67:e0135222.
    >> Share

  67. SHINOHARA K, Fujisawa T, Chang B, Ito Y, et al
    Frequent Transmission of Streptococcus pneumoniae Serotype 35B and 35D, Clonal Complex 558 Lineage, across Continents and the Formation of Multiple Clades in Japan.
    Antimicrob Agents Chemother. 2023 Jan 18:e0108322. doi: 10.1128/aac.01083.
    >> Share

  68. LIU H, Zhu H, Fu L, Zhang W, et al
    Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models.
    Antimicrob Agents Chemother. 2023 Jan 9:e0139922. doi: 10.1128/aac.01399.
    >> Share

  69. REICHLEN MJ, Born SEM, Lyons MA, Rossmassler K, et al
    Standardized RS Ratio Metrics To Assess Tuberculosis Antimicrobial Efficacy and Potency.
    Antimicrob Agents Chemother. 2023 Jan 9:e0148322. doi: 10.1128/aac.01483.
    >> Share

  70. JARRETT RT, van der Heijden Y, Shotwell MS, Chihota V, et al
    High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus.
    Antimicrob Agents Chemother. 2023 Jan 9:e0129722. doi: 10.1128/aac.01297.
    >> Share

  71. BLANCO-DI MATTEO A, Garcia-Fernandez N, Aguinaga Perez A, Carmona-Torre F, et al
    In Vivo Effectiveness of Several Antimicrobial Locks To Eradicate Intravascular Catheter Coagulase-Negative Staphylococci Biofilms.
    Antimicrob Agents Chemother. 2023 Jan 5:e0126422. doi: 10.1128/aac.01264.
    >> Share

  72. BROWN KL, Wilburn KM, Montague CR, Grigg JC, et al
    Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in Mycobacterium tuberculosis by the Novel Drug Candidate GSK2556286.
    Antimicrob Agents Chemother. 2023 Jan 5:e0129422. doi: 10.1128/aac.01294.
    >> Share

  73. ZHANG F, Li Z, Liu X, Luo G, et al
    Molecular Characteristics of an NDM-4 and OXA-181 Co-Producing K51-ST16 Carbapenem-Resistant Klebsiella pneumoniae: Study of Its Potential Dissemination Mediated by Conjugative Plasmids and Insertion Sequences.
    Antimicrob Agents Chemother. 2023 Jan 5:e0135422. doi: 10.1128/aac.01354.
    >> Share

  74. MCNEIL JC, Sommer LM, Vallejo JG, Boyle M, et al
    Going Back in Time: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children.
    Antimicrob Agents Chemother. 2023 Jan 4:e0119622. doi: 10.1128/aac.01196.
    >> Share

    December 2022
  75. SIMAR SR, Tran TT, Rydell KB, Panesso D, et al
    Multisite Detection of Tn1549-Mediated vanB Vancomycin Resistance in Multidrug-Resistant Enterococcus faecalis ST6 in Texas and Florida.
    Antimicrob Agents Chemother. 2022 Dec 21:e0128422. doi: 10.1128/aac.01284.
    >> Share

  76. AHMAD MN, Garg T, Singh S, Shukla R, et al
    In Vitro and In Vivo Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections.
    Antimicrob Agents Chemother. 2022;66:e0056422.
    >> Share

  77. BOONSTRA JM, van der Elst KC, Zijlstra JG, van der Werf TS, et al
    Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Antimicrob Agents Chemother. 2022;66:e0111322.
    >> Share

  78. MANESH A, Devasagayam E, Bhanuprasad K, Mathew SK, et al
    Efficacy of Crushed Delayed-Release Posaconazole Tablets in Rhino-Orbito-Cerebral Mucormycosis.
    Antimicrob Agents Chemother. 2022;66:e0108522.
    >> Share

  79. ZHANG J, Chen L, Gomez-Simmonds A, Yin MT, et al
    Antibiotic-Specific Risk for Community-Acquired Clostridioides difficile Infection in the United States from 2008 to 2020.
    Antimicrob Agents Chemother. 2022;66:e0112922.
    >> Share

  80. PARK YE, Chong YP, Lee HJ, Shim TS, et al
    Clinical Outcome with Standard Regimen plus Clofazimine or Moxifloxacin in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Antimicrob Agents Chemother. 2022;66:e0052822.
    >> Share

  81. BONNET PL, Le Gal S, Gautier C, Hoffmann CV, et al
    Apparent Absence of Selective Pressure on Pneumocystis jirovecii Organisms in Patients with Prior Methotrexate Exposure.
    Antimicrob Agents Chemother. 2022;66:e0099022.
    >> Share

  82. GEHRKE AE, Mendoza-Bertelli A, Ledo C, Gonzalez CD, et al
    Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis.
    Antimicrob Agents Chemother. 2022 Dec 19:e0114022. doi: 10.1128/aac.01140.
    >> Share

  83. KIM J, Choi J, Kang H, Ahn J, et al
    Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial.
    Antimicrob Agents Chemother. 2022 Dec 12:e0112322. doi: 10.1128/aac.01123.
    >> Share

  84. RHODES NJ, Rohani R, Yarnold PR, Pawlowski AE, et al
    Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia.
    Antimicrob Agents Chemother. 2022 Dec 6:e0102322. doi: 10.1128/aac.01023.
    >> Share

  85. MILLER S, Goy K, She R, Spellberg B, et al
    Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella.
    Antimicrob Agents Chemother. 2022 Dec 5:e0132022. doi: 10.1128/aac.01320.
    >> Share

    November 2022
  86. LIU Y, Shi J, Li L, Wu T, et al
    Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Nov 30:e0053122. doi: 10.1128/aac.00531.
    >> Share

  87. WONG CF, Saw WG, Basak S, Sano M, et al
    Structural Elements Involved in ATP Hydrolysis Inhibition and ATP Synthesis of Tuberculosis and Nontuberculous Mycobacterial F-ATP Synthase Decipher New Targets for Inhibitors.
    Antimicrob Agents Chemother. 2022 Nov 29:e0105622. doi: 10.1128/aac.01056.
    >> Share

  88. YU XH, Hao ZH, Liu PL, Liu MM, et al
    Increased Expression of Efflux Pump norA Drives the Rapid Evolutionary Trajectory from Tolerance to Resistance against Ciprofloxacin in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2022 Nov 29:e0059422. doi: 10.1128/aac.00594.
    >> Share

  89. HULL RC, Wright RCT, Sayers JR, Sutton JAF, et al
    Antibiotics Limit Adaptation of Drug-Resistant Staphylococcus aureus to Hypoxia.
    Antimicrob Agents Chemother. 2022 Nov 21:e0092622. doi: 10.1128/aac.00926.
    >> Share

  90. MANSJO M, Karlsson Lindsjo O, Gronfors Seeth C, Groenheit R, et al
    The ddn Trp20Stop Mutation and Its Association with Lineage 4.5 and Resistance to Delamanid and Pretomanid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Nov 21:e0102622. doi: 10.1128/aac.01026.
    >> Share

  91. LYONS MA
    Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide.
    Antimicrob Agents Chemother. 2022 Nov 15:e0089822. doi: 10.1128/aac.00898.
    >> Share

  92. NELSON M, Burton N, Nunez A, Butcher W, et al
    Efficacy of Co-Trimoxazole against Experimental Melioidosis Acquired by Different Routes of Infection.
    Antimicrob Agents Chemother. 2022;66:e0070822.
    >> Share

  93. MCCOLLAM S, Lewis JS 2nd, Bubalo J, Diaz A, et al
    Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
    Antimicrob Agents Chemother. 2022;66:e0083322.
    >> Share

  94. WINTERS CG, Basnet RM, Faasuamalie PE, Shallom SJ, et al
    Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model.
    Antimicrob Agents Chemother. 2022;66:e0053922.
    >> Share

  95. SAH SK, Bhattacharya S, Yadav A, Husain F, et al
    Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.
    Antimicrob Agents Chemother. 2022 Nov 10:e0097722. doi: 10.1128/aac.00977.
    >> Share

  96. YEO HH, Shiau CW, Jao YH, Wan TW, et al
    Rapid Bactericidal Activity of SC5005 Combined with Docosahexaenoic Acid against Multidrug-Resistant Staphylococcus aureus Persisters and Biofilms.
    Antimicrob Agents Chemother. 2022 Nov 10:e0080322. doi: 10.1128/aac.00803.
    >> Share

  97. SARATHY JP, Zimmerman MD, Gengenbacher M, Dartois V, et al
    Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro.
    Antimicrob Agents Chemother. 2022 Nov 9:e0123722. doi: 10.1128/aac.01237.
    >> Share

  98. DEVENTER AT, Bryson D, Shortill M, Boraston AB, et al
    Molecular Characterization of Clinical Rel Mutations and Consequences for Resistance Expression and Fitness in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2022 Nov 8:e0093822. doi: 10.1128/aac.00938.
    >> Share

  99. MON AS, Ei PW, Htwe MM, Nyunt MH, et al
    First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar.
    Antimicrob Agents Chemother. 2022 Nov 7:e0092522. doi: 10.1128/aac.00925.
    >> Share

  100. CABELLOS C, Guillem L, Pelegrin I, Tubau F, et al
    Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
    Antimicrob Agents Chemother. 2022 Nov 3:e0082022. doi: 10.1128/aac.00820.
    >> Share

  101. NGUYEN TQ, Hanh BTB, Jeon S, Heo BE, et al
    Synergistic Effect of Q203 Combined with PBTZ169 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Nov 2:e0044822. doi: 10.1128/aac.00448.
    >> Share

    October 2022
  102. AN L, Tan J, Wang Y, Liu S, et al
    Synergistic Effect of the Combination of Deferoxamine and Fluconazole In Vitro and In Vivo against Fluconazole-Resistant Candida Spp.
    Antimicrob Agents Chemother. 2022 Oct 26:e0072522. doi: 10.1128/aac.00725.
    >> Share

  103. SINGH KV, Montealegre MC, Murray BE
    Enterococcus faecium Clade Competition in the Presence of beta-Lactam Antibiotics in a Mouse GI Tract Colonization Model.
    Antimicrob Agents Chemother. 2022 Oct 18:e0090322. doi: 10.1128/aac.00903.
    >> Share

  104. MCNEIL JC, Sommer LM, Vallejo JG, Hulten KG, et al
    Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation.
    Antimicrob Agents Chemother. 2022;66:e0074522.
    >> Share

  105. KIM SR, Jang M, Kim SY, Kim DH, et al
    Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease.
    Antimicrob Agents Chemother. 2022;66:e0077422.
    >> Share

  106. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
    Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2022;66:e0061822.
    >> Share

  107. PHIPPS AJ, Bergmann JN, Albrecht MT, Singh VK, et al
    Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose.
    Antimicrob Agents Chemother. 2022;66:e0054622.
    >> Share

  108. AL-ZUBAIDI A, Cheung CY, Cook GM, Taiaroa G, et al
    RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria.
    Antimicrob Agents Chemother. 2022;66:e0209121.
    >> Share

  109. FINDLAY J, Rens C, Poirel L, Nordmann P, et al
    In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2022;66:e0091822.
    >> Share

  110. PINCUS NB, Rosas-Lemus M, Gatesy SWM, Bertucci HK, et al
    Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family beta-Lactamase from Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2022;66:e0098522.
    >> Share

  111. MON KKZ, Si Z, Chan-Park MB, Kenney LJ, et al
    Polyimidazolium Protects against an Invasive Clinical Isolate of Salmonella Typhimurium.
    Antimicrob Agents Chemother. 2022;66:e0059722.
    >> Share

  112. KUNZ COYNE AJ, Alshaer M, Casapao AM, Venugopalan V, et al
    Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection.
    Antimicrob Agents Chemother. 2022;66:e0064622.
    >> Share

  113. KIM TY, Huh HJ, Lee GY, Choi MJ, et al
    Evolution of Fluconazole Resistance Mechanisms and Clonal Types of Candida parapsilosis Isolates from a Tertiary Care Hospital in South Korea.
    Antimicrob Agents Chemother. 2022 Oct 13:e0088922. doi: 10.1128/aac.00889.
    >> Share

  114. HISATSUNE J, Tanimoto K, Kohara T, Myoken Y, et al
    First Isolation of Vancomycin-Resistant Enterococcus faecium Carrying Plasmid-Borne vanD1.
    Antimicrob Agents Chemother. 2022 Oct 12:e0102922. doi: 10.1128/aac.01029.
    >> Share

  115. PLAUNT AJ, Rose SJ, Kang JY, Chen KJ, et al
    Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections".
    Antimicrob Agents Chemother. 2022 Oct 12:e0125622. doi: 10.1128/aac.01256.
    >> Share

  116. YAO S, Wei D, Tang N, Song Y, et al
    Efficient Suppression of Natural Plasmid-Borne Gene Expression in Carbapenem-Resistant Klebsiella pneumoniae Using a Compact CRISPR Interference System.
    Antimicrob Agents Chemother. 2022 Oct 12:e0089022. doi: 10.1128/aac.00890.
    >> Share

  117. PI R, Chen X, Meng J, Liu Q, et al
    Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Oct 3:e0103422. doi: 10.1128/aac.01034.
    >> Share

  118. RAMBACH G, Striednig B, Neurauter M, Hermann M, et al
    Indications that the Antimycotic Drug Amphotericin B Enhances the Impact of Platelets on Aspergillus.
    Antimicrob Agents Chemother. 2022 Oct 3:e0068122. doi: 10.1128/aac.00681.
    >> Share

    September 2022
  119. MENDES RE, Hubler C, Kimbrough JH, Kantro V, et al
    In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020).
    Antimicrob Agents Chemother. 2022 Sep 28:e0121422. doi: 10.1128/aac.01214.
    >> Share

  120. YAMADA W, Kim S, Almoslem M, Kim S, et al
    Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype.
    Antimicrob Agents Chemother. 2022 Sep 27:e0069522. doi: 10.1128/aac.00695.
    >> Share

  121. COX GW, Avery BP, Parmley EJ, Irwin RJ, et al
    A One Health Genomic Investigation of Gentamicin Resistance in Escherichia coli from Human and Chicken Sources in Canada, 2014 to 2017.
    Antimicrob Agents Chemother. 2022 Sep 27:e0067722. doi: 10.1128/aac.00677.
    >> Share

  122. CUSUMANO JA, Daffinee KE, Piehl EC, Garcia-Solache M, et al
    Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an In Vitro Pharmacodynamic Model Using Humanized Dosing Simulations.
    Antimicrob Agents Chemother. 2022 Sep 26:e0042622. doi: 10.1128/aac.00426.
    >> Share

  123. RUEGSEGGER L, Xiao J, Naziripour A, Kanumuambidi T, et al
    Multidrug-Resistant Gram-Negative Bacteria in Burn Patients.
    Antimicrob Agents Chemother. 2022;66:e0068822.
    >> Share

  124. LIU F, Gao J, Gao M, Liu Y, et al
    Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study.
    Antimicrob Agents Chemother. 2022;66:e0203321.
    >> Share

  125. MADANI A, Negatu DA, El Marrouni A, Miller RR, et al
    Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0066922.
    >> Share

  126. KARLOWSKY JA, Hackel MA, McLeod SM, Miller AA, et al
    In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021.
    Antimicrob Agents Chemother. 2022;66:e0078122.
    >> Share

  127. HOBSON CA, Pierrat G, Tenaillon O, Bonacorsi S, et al
    Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
    Antimicrob Agents Chemother. 2022;66:e0044722.
    >> Share

  128. JEN FE, Edwards JL, El-Deeb IM, Walker MJ, et al
    Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections.
    Antimicrob Agents Chemother. 2022;66:e0231821.
    >> Share

  129. PARK S, Russo R, Westfall L, Shrestha R, et al
    A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens.
    Antimicrob Agents Chemother. 2022;66:e0041422.
    >> Share

  130. LEWIS JS 2ND, Wiederhold NP, Hakki M, Thompson GR 3rd, et al
    New Perspectives on Antimicrobial Agents: Isavuconazole.
    Antimicrob Agents Chemother. 2022;66:e0017722.
    >> Share

  131. WU W, He S, Li A, Guo Q, et al
    A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2022;66:e0060122.
    >> Share

  132. CHAE G, Park YE, Chong YP, Lee HJ, et al
    Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
    Antimicrob Agents Chemother. 2022;66:e0226121.
    >> Share

  133. BROWN-ELLIOTT BA, Wallace RJ Jr
    In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2022;66:e0068922.
    >> Share

  134. LUTERBACH CL, Qiu H, Hanafin PO, Sharma R, et al
    A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Antimicrob Agents Chemother. 2022 Sep 20:e0059122. doi: 10.1128/aac.00591.
    >> Share

  135. ZOU J, Chen S, Rao W, Fu L, et al
    Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China.
    Antimicrob Agents Chemother. 2022 Sep 15:e0081122. doi: 10.1128/aac.00811.
    >> Share

  136. SUNDELL J, Bienvenu E, Birgersson S, Abelo A, et al
    Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients.
    Antimicrob Agents Chemother. 2022 Sep 7:e0227721. doi: 10.1128/aac.02277.
    >> Share

  137. STANTON RA, Campbell D, McAllister GA, Breaker E, et al
    Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.
    Antimicrob Agents Chemother. 2022 Sep 6:e0049622. doi: 10.1128/aac.00496.
    >> Share

    August 2022
  138. KIM LH, Kang SM, Whang J, Kwon KW, et al
    Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.
    Antimicrob Agents Chemother. 2022 Aug 30:e0076222. doi: 10.1128/aac.00762.
    >> Share

  139. SHEE S, Singh S, Tripathi A, Thakur C, et al
    Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species.
    Antimicrob Agents Chemother. 2022 Aug 17:e0059222. doi: 10.1128/aac.00592.
    >> Share

  140. SARIS A, Qin W, van Linge CCA, Reijnders TDY, et al
    The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2022 Aug 16:e0229821. doi: 10.1128/aac.02298.
    >> Share

  141. POIREL L, Ortiz de la Rosa JM, Sakaoglu Z, Kusaksizoglu A, et al
    NDM-35-Producing ST167 Escherichia coli Highly Resistant to beta-Lactams Including Cefiderocol.
    Antimicrob Agents Chemother. 2022;66:e0031122.
    >> Share

  142. MENON ND, Penziner S, Montano ET, Zurich R, et al
    Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2022;66:e0023922.
    >> Share

  143. MCPHERSON J, Hu C, Begum K, Wang W, et al
    Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection.
    Antimicrob Agents Chemother. 2022;66:e0224421.
    >> Share

  144. OSTAPSKA H, Raju D, Corsini R, Lehoux M, et al
    Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases as Antibiofilm Agents in Acute Pulmonary Pseudomonas aeruginosa Infection.
    Antimicrob Agents Chemother. 2022;66:e0005222.
    >> Share

  145. COSTA DVS, Pham NVS, Hays RA, Bolick DT, et al
    Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Antimicrob Agents Chemother. 2022;66:e0048922.
    >> Share

  146. WIEDERHOLD NP, Patterson TF, Rebholz S, Boal CWC, et al
    The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate).
    Antimicrob Agents Chemother. 2022;66:e0052122.
    >> Share

  147. CHOCHUA S, Metcalf B, Li Z, Mathis S, et al
    Invasive Group A Streptococcal Penicillin Binding Protein 2x Variants Associated with Reduced Susceptibility to beta-Lactam Antibiotics in the United States, 2015-2021.
    Antimicrob Agents Chemother. 2022 Aug 15:e0080222. doi: 10.1128/aac.00802.
    >> Share

  148. GEBERETSADIK G, Inaizumi A, Nishiyama A, Yamaguchi T, et al
    Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs.
    Antimicrob Agents Chemother. 2022 Aug 15:e0017122. doi: 10.1128/aac.00171.
    >> Share

  149. VALCEK A, Nesporova K, Whiteway C, De Pooter T, et al
    Genomic Analysis of a Strain Collection Containing Multidrug-, Extensively Drug-, Pandrug-, and Carbapenem-Resistant Modern Clinical Isolates of Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2022 Aug 15:e0089222. doi: 10.1128/aac.00892.
    >> Share

  150. BRUNAUGH AD, Walz A, Warnken Z, Pearce C, et al
    Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.
    Antimicrob Agents Chemother. 2022 Aug 9:e0018622. doi: 10.1128/aac.00186.
    >> Share

  151. BARNIER JP, Saidjalolov S, Bouchet F, Mayer L, et al
    Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Aug 9:e0235721. doi: 10.1128/aac.02357.
    >> Share

  152. YUN HY, Chang MJ, Jung H, Chang V, et al
    Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.
    Antimicrob Agents Chemother. 2022 Aug 8:e0189321. doi: 10.1128/aac.01893.
    >> Share

  153. DING Y, Zhu H, Fu L, Zhang W, et al
    Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis.
    Antimicrob Agents Chemother. 2022 Aug 4:e0065822. doi: 10.1128/aac.00658.
    >> Share

  154. ESCRIBANO P, Gomez A, Reigadas E, Munoz P, et al
    EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings.
    Antimicrob Agents Chemother. 2022 Aug 4:e0084922. doi: 10.1128/aac.00849.
    >> Share

  155. POULTON NC, Azadian ZA, DeJesus MA, Rock JM, et al
    Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Aug 3:e0090422. doi: 10.1128/aac.00904.
    >> Share

  156. COLABARDINI AC, Van Rhijn N, LaBella AL, Valero C, et al
    Aspergillus fumigatus FhdA Transcription Factor Is Important for Mitochondrial Activity and Codon Usage Regulation during the Caspofungin Paradoxical Effect.
    Antimicrob Agents Chemother. 2022 Aug 2:e0070122. doi: 10.1128/aac.00701.
    >> Share

  157. EDLIND T, Katiyar S
    Intrinsically High Resistance of Candida glabrata to Hydrogen Peroxide and Its Reversal in a Fluconazole-Resistant Mutant.
    Antimicrob Agents Chemother. 2022 Aug 2:e0072122. doi: 10.1128/aac.00721.
    >> Share

  158. GRACIAA DS, Kipiani M, Magee MJ, Mikiashvili L, et al
    Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2022 Aug 2:e0040822. doi: 10.1128/aac.00408.
    >> Share

    July 2022
  159. SHELTON CD, McNeil MB, Early JV, Ioerger TR, et al
    Correction for Shelton et al., "Deletion of Rv2571c Confers Resistance to Arylamide Compounds in Mycobacterium tuberculosis".
    Antimicrob Agents Chemother. 2022 Jul 25:e0096222. doi: 10.1128/aac.00962.
    >> Share

  160. CHANG SC, Lin LC, Lu JJ
    An lnu(A)-Carrying Multi-Resistance Plasmid Derived from Sequence Type 3 Methicillin-Resistant Staphylococcus lugdunensis May Contribute to Antimicrobial Resistance in Staphylococci.
    Antimicrob Agents Chemother. 2022 Jul 25:e0019722. doi: 10.1128/aac.00197.
    >> Share

  161. HARISH E, Sarkar A, Handelman M, Abo Kandil A, et al
    Triazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2022 Jul 20:e0045822. doi: 10.1128/aac.00458.
    >> Share

  162. LOPEZ-CERERO L, Stolz E, Pulido MR, Pascual A, et al
    Characterization of Extended-Spectrum beta-Lactamase-Producing Shigella sonnei in Spain: Expanding the Geographic Distribution of Sequence Type 152/CTX-M-27 Clone.
    Antimicrob Agents Chemother. 2022;66:e0033422.
    >> Share

  163. DAI YY, Qin C, Huang GR, Qin YC, et al
    Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori.
    Antimicrob Agents Chemother. 2022;66:e0007322.
    >> Share

  164. MADDEN GR, Petri WA Jr, Costa DVS, Warren CA, et al
    Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes.
    Antimicrob Agents Chemother. 2022;66:e0067622.
    >> Share

  165. O'DONNELL JN, Lodise TP
    New Perspectives on Antimicrobial Agents: Imipenem-Relebactam.
    Antimicrob Agents Chemother. 2022;66:e0025622.
    >> Share

  166. SEN T, Verma NK
    Functional Role of YnfA, an Efflux Transporter in Resistance to Antimicrobial Agents in Shigella flexneri.
    Antimicrob Agents Chemother. 2022;66:e0029322.
    >> Share

  167. PARK JJ, Jung EJ, Kim JY, Seo YB, et al
    Thirty-Day Mortality Rates in Patients with Extended-Spectrum beta-Lactamase-Producing Enterobacterales Bacteremia Receiving Ertapenem versus Other Carbapenems.
    Antimicrob Agents Chemother. 2022;66:e0028722.
    >> Share

  168. DESAI JV, Urban A, Swaim DZ, Colton B, et al
    Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.
    Antimicrob Agents Chemother. 2022;66:e0030822.
    >> Share

  169. GEBREMARIAM T, Gu Y, Alkhazraji S, Youssef E, et al
    The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections.
    Antimicrob Agents Chemother. 2022;66:e0038022.
    >> Share

  170. PITOUT JDD, Peirano G, Chen L, DeVinney R, et al
    Escherichia coli ST1193: Following in the Footsteps of E. coli ST131.
    Antimicrob Agents Chemother. 2022;66:e0051122.
    >> Share

  171. MTSHALI S, Jacobs BA
    A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections.
    Antimicrob Agents Chemother. 2022 Jul 19:e0027422. doi: 10.1128/aac.00274.
    >> Share

  172. DIAZ-GARCIA J, Gomez A, Alcala L, Reigadas E, et al
    Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution.
    Antimicrob Agents Chemother. 2022 Jul 19:e0071022. doi: 10.1128/aac.00710.
    >> Share

  173. MEHTA K, Guo T, Wallis RS, van der Graaf PH, et al
    Quantitative Systems Pharmacology Modeling Framework of Autophagy in Tuberculosis: Application to Adjunctive Metformin Host-Directed Therapy.
    Antimicrob Agents Chemother. 2022 Jul 14:e0036622. doi: 10.1128/aac.00366.
    >> Share

  174. KONG X, Wang B, Chen X, Wang L, et al
    Hinokiflavone Attenuates the Virulence of Methicillin-Resistant Staphylococcus aureus by Targeting Caseinolytic Protease P.
    Antimicrob Agents Chemother. 2022 Jul 11:e0024022. doi: 10.1128/aac.00240.
    >> Share

  175. KNOLL MA, Samardzic E, Posch W, Lass-Florl C, et al
    Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata.
    Antimicrob Agents Chemother. 2022 Jul 11:e0016822. doi: 10.1128/aac.00168.
    >> Share

  176. SOUCHE A, Kolenda C, Teoli J, Schuch R, et al
    Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections.
    Antimicrob Agents Chemother. 2022 Jul 11:e0058822. doi: 10.1128/aac.00588.
    >> Share

  177. WATANABE F, Furuuchi K, Hanada K, Fujiwara K, et al
    Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.
    Antimicrob Agents Chemother. 2022 Jul 7:e0044122. doi: 10.1128/aac.00441.
    >> Share

    June 2022
  178. JACOBS SE, Jacobs JL, Dennis EK, Taimur S, et al
    Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
    Antimicrob Agents Chemother. 2022 Jun 30:e0005322. doi: 10.1128/aac.00053.
    >> Share

  179. HSU AJ, Tamma PD, Fisher BT
    Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.
    Antimicrob Agents Chemother. 2022 Jun 29:e0215621. doi: 10.1128/aac.02156.
    >> Share

  180. BAE S, Kim ES, Kim HS, Yang E, et al
    Risk Factors of Recurrent Infection in Patients with Staphylococcus aureus Bacteremia: a Competing Risk Analysis.
    Antimicrob Agents Chemother. 2022 Jun 28:e0012622. doi: 10.1128/aac.00126.
    >> Share

  181. RIVIERE E, Verboven L, Dippenaar A, Goossens S, et al
    Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis Lineage.
    Antimicrob Agents Chemother. 2022 Jun 27:e0032222. doi: 10.1128/aac.00322.
    >> Share

  182. KWIECINSKI JM, Jelani DA, Fuentes EJ, Horswill AR, et al
    Therapeutic Inhibition of Staphylococcus aureus ArlRS Two-Component Regulatory System Blocks Virulence.
    Antimicrob Agents Chemother. 2022 Jun 23:e0018722. doi: 10.1128/aac.00187.
    >> Share

  183. ABOLHASSANI-CHIMEH R, Akkerman OW, Saktiawati AMI, Punt NC, et al
    Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2022 Jun 21:e0000322. doi: 10.1128/aac.00003.
    >> Share

  184. PHILLIPS EC, Warren CA, Ma JZ, Madden GR, et al
    Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.
    Antimicrob Agents Chemother. 2022;66:e0000122.
    >> Share

  185. RIMAL B, Batchelder HR, Story-Roller E, Panthi CM, et al
    T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with beta-Lactams Imipenem and Cefditoren.
    Antimicrob Agents Chemother. 2022;66:e0053622.
    >> Share

  186. XIE J, Yang Q, Han X, Dong Y, et al
    Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.
    Antimicrob Agents Chemother. 2022;66:e0009922.
    >> Share

  187. WILLIAMS E, Zhang B, Chow EPF, Chea S, et al
    Inhibitory Activity of Antibacterial Mouthwashes and Antiseptic Substances against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2022;66:e0004222.
    >> Share

  188. HUGGINS JP, Pease R, Stanly K, Workman A, et al
    Safety of Inhaled Amphotericin B Lipid Complex as Antifungal Prophylaxis in Lung Transplant Recipients.
    Antimicrob Agents Chemother. 2022;66:e0028322.
    >> Share

  189. TRAN TT, Gomez Villegas S, Aitken SL, Butler-Wu SM, et al
    New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.
    Antimicrob Agents Chemother. 2022;66:e0261420.
    >> Share

  190. WALTER K, Kokesch-Himmelreich J, Treu A, Waldow F, et al
    Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.
    Antimicrob Agents Chemother. 2022;66:e0158821.
    >> Share

  191. TONG K, Wei J, Gu H, Hu Q, et al
    Evaluation of Experimental and Clinical Efficacy on Surgical Debridement and Systemic Antibiotics Treatment for Early Knee Infection after Anterior Cruciate Ligament Reconstruction.
    Antimicrob Agents Chemother. 2022;66:e0011222.
    >> Share

  192. MCCALLIN S, Menzi C, Lassen S, Daraspe J, et al
    Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA).
    Antimicrob Agents Chemother. 2022 Jun 16:e0224721. doi: 10.1128/aac.02247.
    >> Share

  193. DOORLEY LA, Rybak JM, Berkow EL, Zhang Q, et al
    Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance.
    Antimicrob Agents Chemother. 2022 Jun 14:e0028922. doi: 10.1128/aac.00289.
    >> Share

  194. SONG W, Wang L, Jin M, Guo X, et al
    Punicalagin, an Inhibitor of Sortase A, Is a Promising Therapeutic Drug to Combat Methicillin-Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2022 Jun 2:e0022422. doi: 10.1128/aac.00224.
    >> Share

  195. SHIVARATHRI R, Jenull S, Chauhan M, Singh A, et al
    Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris.
    Antimicrob Agents Chemother. 2022 Jun 2:e0227621. doi: 10.1128/aac.02276.
    >> Share

  196. SHAO Y, Chen M, Luo J, Li D, et al
    Serogroup Y Clonal Complex 23 Meningococcus in China Acquiring Penicillin Resistance from Commensal Neisseria lactamica Species.
    Antimicrob Agents Chemother. 2022 Jun 2:e0238321. doi: 10.1128/aac.02383.
    >> Share

  197. ZHOU Y, Zhong Z, Hu S, Wang J, et al
    A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China.
    Antimicrob Agents Chemother. 2022 Jun 2:e0218821. doi: 10.1128/aac.02188.
    >> Share

  198. CHEN M, Zhong G, Wang S, Chen P, et al
    Deletion of cox7c Results in Pan-Azole Resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2022 Jun 1:e0015122. doi: 10.1128/aac.00151.
    >> Share

  199. ISHIKAWA K, Uehara Y, Mori N, Mikami Y, et al
    In Vitro Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2022 Jun 1:e0012522. doi: 10.1128/aac.00125.
    >> Share

    May 2022
  200. NUERMBERGER EL, Martinez-Martinez MS, Sanz O, Urones B, et al
    GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
    Antimicrob Agents Chemother. 2022 May 24:e0013222. doi: 10.1128/aac.00132.
    >> Share

  201. SOBEL JD, Akins R
    Determining Susceptibility in Candida Vaginal Isolates.
    Antimicrob Agents Chemother. 2022 May 23:e0236621. doi: 10.1128/aac.02366.
    >> Share

  202. KARLOWSKY JA, Lob SH, DeRyke CA, Hilbert DW, et al
    In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 202
    Antimicrob Agents Chemother. 2022;66:e0018922.
    >> Share

  203. LI X, Le W, Lou X, Genco CA, et al
    In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019).
    Antimicrob Agents Chemother. 2022;66:e0010922.
    >> Share

  204. MURRAY GL, Bodiyabadu K, Vodstrcil LA, Machalek DA, et al
    parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure.
    Antimicrob Agents Chemother. 2022;66:e0027822.
    >> Share

  205. PRASAD NK, Seiple IB, Cirz RT, Rosenberg OS, et al
    Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.
    Antimicrob Agents Chemother. 2022;66:e0005422.
    >> Share

  206. GAO W, Passarell J, Patel YT, Zhang Z, et al
    Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP.
    Antimicrob Agents Chemother. 2022;66:e0139921.
    >> Share

  207. PAUL A, Nair RR, Jakkala K, Pradhan A, et al
    Elevated Levels of Three Reactive Oxygen Species and Fe(II) in the Antibiotic-Surviving Population of Mycobacteria Facilitate De Novo Emergence of Genetic Resisters to Antibiotics.
    Antimicrob Agents Chemother. 2022;66:e0228521.
    >> Share

  208. HUJER AM, Bethel CR, Taracila MA, Marshall SH, et al
    Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant beta-Lactamases and Their Increasing Importance.
    Antimicrob Agents Chemother. 2022;66:e0179021.
    >> Share

  209. SCHULTHESS B, Akdogan Kittana FN, Homke R, Sander P, et al
    In Vitro Bedaquiline and Clofazimine Susceptibility Testing in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0234621.
    >> Share

  210. CHUA TP, Danielewski J, Bodiyabadu K, Bradshaw CS, et al
    Impact of 16S rRNA Single Nucleotide Polymorphisms on Mycoplasma genitalium Organism Load with Doxycycline Treatment.
    Antimicrob Agents Chemother. 2022;66:e0024322.
    >> Share

  211. LANDLINGER C, Oberbauer V, Podpera Tisakova L, Schwebs T, et al
    Preclinical Data on the Gardnerella-Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance of Resistance.
    Antimicrob Agents Chemother. 2022;66:e0231921.
    >> Share

  212. DESNOS-OLLIVIER M, Bretagne S, Lortholary O, Dromer F, et al
    Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations.
    Antimicrob Agents Chemother. 2022;66:e0172521.
    >> Share

  213. KARABA SM, Hirsch EB, Heil EL
    In a Pinch: Cefiderocol for CRAB Infections.
    Antimicrob Agents Chemother. 2022;66:e0006522.
    >> Share

  214. KARABASEVIC N, Roberts JA, Stronach L, Naicker S, et al
    Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.
    Antimicrob Agents Chemother. 2022;66:e0214021.
    >> Share

  215. ERSOY SC, Manna AC, Proctor RA, Chambers HF, et al
    The NaHCO3-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus (MRSA) Is Influenced by mecA Genotype.
    Antimicrob Agents Chemother. 2022 May 16:e0025222. doi: 10.1128/aac.00252.
    >> Share

  216. SUPANDY A, Mehta HH, Tran TT, Miller WR, et al
    Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive Strategies.
    Antimicrob Agents Chemother. 2022 May 11:e0233321. doi: 10.1128/aac.02333.
    >> Share

  217. FUCHS F, Aldejohann AM, Hoffmann AM, Walther G, et al
    In Vitro Activity of Nitroxoline in Antifungal-Resistant Candida Species Isolated from the Urinary Tract.
    Antimicrob Agents Chemother. 2022 May 11:e0226521. doi: 10.1128/aac.02265.
    >> Share

  218. MOURAD A, Holland TL, Turner NA
    Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
    Antimicrob Agents Chemother. 2022 May 10:e0036522. doi: 10.1128/aac.00365.
    >> Share

  219. CONKLE-GUTIERREZ D, Kim C, Ramirez-Busby SM, Modlin SJ, et al
    Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study.
    Antimicrob Agents Chemother. 2022 May 9:e0207521. doi: 10.1128/aac.02075.
    >> Share

  220. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Chirehwa M, et al
    Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2022 May 4:e0226421. doi: 10.1128/aac.02264.
    >> Share

    April 2022
  221. RAGUNATHAN P, Dick T, Gruber G
    Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1.
    Antimicrob Agents Chemother. 2022 Apr 28:e0001822. doi: 10.1128/aac.00018.
    >> Share

  222. MADDEN DE, Olagoke O, Baird T, Neill J, et al
    Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2022 Apr 25:e0020422. doi: 10.1128/aac.00204.
    >> Share

  223. HOLLEY CL, Dhulipala V, Balthazar JT, Le Van A, et al
    A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2022 Apr 25:e0025122. doi: 10.1128/aac.00251.
    >> Share

  224. SALAMA OE, Gerstein AC
    Differential Response of Candida Species Morphologies and Isolates to Fluconazole and Boric Acid.
    Antimicrob Agents Chemother. 2022 Apr 21:e0240621. doi: 10.1128/aac.02406.
    >> Share

  225. ROUCHON CN, Harris J, Zubair-Nizami Z, Weinstein AJ, et al
    The Cationic Antimicrobial Peptide Activity of Lysozyme Reduces Viable Enterococcus faecalis Cells in Biofilms.
    Antimicrob Agents Chemother. 2022 Apr 21:e0233921. doi: 10.1128/aac.02339.
    >> Share

  226. SRIVASTAVA S, Boorgula GD, Wang JY, Huang HL, et al
    Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection.
    Antimicrob Agents Chemother. 2022;66:e0232021.
    >> Share

  227. POIREL L, Ortiz de la Rosa JM, Sadek M, Nordmann P, et al
    Impact of Acquired Broad-Spectrum beta-Lactamases on Susceptibility to Cefiderocol and Newly Developed beta-Lactam/beta-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2022;66:e0003922.
    >> Share

  228. RAJA SM, Guptill JT, Juel VC, Walter EB, et al
    First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.
    Antimicrob Agents Chemother. 2022;66:e0173221.
    >> Share

  229. TARACILA MA, Bethel CR, Hujer AM, Papp-Wallace KM, et al
    Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC beta-Lactamase.
    Antimicrob Agents Chemother. 2022;66:e0212421.
    >> Share

  230. KUREPINA N, Chen L, Composto K, Rifat D, et al
    CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on beta-Lactam Susceptibility.
    Antimicrob Agents Chemother. 2022;66:e0009322.
    >> Share

  231. LIPORAGI LOPES LC, Korangath P, Dos Santos SR Jr, Gabrielson KL, et al
    Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.
    Antimicrob Agents Chemother. 2022;66:e0239921.
    >> Share

  232. MOON SM, Kim SY, Kim DH, Huh HJ, et al
    Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease.
    Antimicrob Agents Chemother. 2022;66:e0202721.
    >> Share

  233. ANDRADE ESN, Brandao JG, Silva JSD, Coriolano CRF, et al
    Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
    Antimicrob Agents Chemother. 2022 Apr 18:e0217021. doi: 10.1128/aac.02170.
    >> Share

  234. EICHENSEHER F, Herpers BL, Badoux P, Leyva-Castillo JM, et al
    Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection.
    Antimicrob Agents Chemother. 2022 Apr 13:e0227321. doi: 10.1128/aac.02273.
    >> Share

  235. CAFFREY AR, Appaneal HJ, LaPlante KL, Lopes VV, et al
    Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.
    Antimicrob Agents Chemother. 2022 Apr 13:e0211721. doi: 10.1128/aac.02117.
    >> Share

  236. GARCIA-PRATS AJ, Frias M, van der Laan L, De Leon A, et al
    Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
    Antimicrob Agents Chemother. 2022 Apr 11:e0214421. doi: 10.1128/aac.02144.
    >> Share

  237. CHAUHAN U, Barth VC, Woychik NA
    tRNA(fMet) Inactivating Mycobacterium tuberculosis VapBC Toxin-Antitoxin Systems as Therapeutic Targets.
    Antimicrob Agents Chemother. 2022 Apr 11:e0189621. doi: 10.1128/aac.01896.
    >> Share

  238. ZHANG T, Yu X, Wen S, Xue Y, et al
    Bone Penetration of Cycloserine in Osteoarticular Tuberculosis Patients of China.
    Antimicrob Agents Chemother. 2022 Apr 11:e0222421. doi: 10.1128/aac.02224.
    >> Share

  239. VAN VLIET AHM, Thakur S, Prada JM, Mehat JW, et al
    Genomic Screening of Antimicrobial Resistance Markers in UK and US Campylobacter Isolates Highlights Stability of Resistance over an 18-Year Period.
    Antimicrob Agents Chemother. 2022 Apr 11:e0168721. doi: 10.1128/aac.01687.
    >> Share

    March 2022
  240. LIN X, Qin X, Wu X, Liao Y, et al
    Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.
    Antimicrob Agents Chemother. 2022 Mar 29:e0229421. doi: 10.1128/aac.02294.
    >> Share

  241. SONG N, Zhou X, Li D, Li X, et al
    A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance.
    Antimicrob Agents Chemother. 2022 Mar 28:e0210521. doi: 10.1128/aac.02105.
    >> Share

  242. LI J, Coste AT, Bachmann D, Sanglard D, et al
    Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
    Antimicrob Agents Chemother. 2022 Mar 28:e0006722. doi: 10.1128/aac.00067.
    >> Share

  243. TASNEEN R, Garcia A, Converse PJ, Zimmerman MD, et al
    Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
    Antimicrob Agents Chemother. 2022 Mar 22:e0239821. doi: 10.1128/aac.02398.
    >> Share

  244. JI X, Kruger H, Wang Y, Fessler AT, et al
    Tn560, a Novel Tn554 Family Transposon from Porcine Methicillin-Resistant Staphylococcus aureus ST398, Carries a Multiresistance Gene Cluster Comprising a Novel spc Gene Variant and the Genes lsa(E) and lnu(B).
    Antimicrob Agents Chemother. 2022 Mar 22:e0194721. doi: 10.1128/aac.01947.
    >> Share

  245. DIDE-AGOSSOU C, Bauman AA, Ramey ME, Rossmassler K, et al
    Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments.
    Antimicrob Agents Chemother. 2022 Mar 21:e0231021. doi: 10.1128/aac.02310.
    >> Share

  246. ROTHSTEIN TE, Cunningham SA, Rieke RA, Mainella JM, et al
    Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021.
    Antimicrob Agents Chemother. 2022 Mar 21:e0243221. doi: 10.1128/aac.02432.
    >> Share

  247. BILAL H, Tait JR, Lang Y, Zhou J, et al
    Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
    Antimicrob Agents Chemother. 2022;66:e0220321.
    >> Share

  248. BLASCO L, Bleriot I, Gonzalez de Aledo M, Fernandez-Garcia L, et al
    Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.
    Antimicrob Agents Chemother. 2022;66:e0192321.
    >> Share

  249. BUTLER MS, Gigante V, Sati H, Paulin S, et al
    Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
    Antimicrob Agents Chemother. 2022;66:e0199121.
    >> Share

  250. KURBATFINSKI N, Goodman SD, Bakaletz LO
    A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics.
    Antimicrob Agents Chemother. 2022;66:e0187721.
    >> Share

  251. APPANEAL HJ, Lopes VV, LaPlante KL, Caffrey AR, et al
    Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection.
    Antimicrob Agents Chemother. 2022;66:e0197521.
    >> Share

  252. LI Y, Zhang L, Xiu L, Wang D, et al
    A Multiplex Molecular Assay for Detection of Six penA Codons To Predict Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2022;66:e0170921.
    >> Share

  253. SAWATZKY P, Demczuk W, Lefebvre B, Allen V, et al
    Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018.
    Antimicrob Agents Chemother. 2022;66:e0168821.
    >> Share

  254. PALLIYIL S, Mawer M, Alawfi SA, Fogg L, et al
    Monoclonal Antibodies Targeting Surface-Exposed Epitopes of Candida albicans Cell Wall Proteins Confer In Vivo Protection in an Infection Model.
    Antimicrob Agents Chemother. 2022 Mar 14:e0195721. doi: 10.1128/aac.01957.
    >> Share

  255. LI LH, Lu HF, Liu YF, Lin YT, et al
    FadACB and smeU1VWU2X Contribute to Oxidative Stress-Mediated Fluoroquinolone Resistance in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2022 Mar 14:e0204321. doi: 10.1128/aac.02043.
    >> Share

  256. BASARAB GS, Ghorpade S, Gibhard L, Mueller R, et al
    Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones.
    Antimicrob Agents Chemother. 2022 Mar 10:e0219221. doi: 10.1128/aac.02192.
    >> Share

  257. KLEINHENZ M, Beesetty P, Yang C, Li Z, et al
    Antibiotic Treatment of Staphylococcus aureus Infection Inhibits the Development of Protective Immunity.
    Antimicrob Agents Chemother. 2022 Mar 10:e0227021. doi: 10.1128/aac.02270.
    >> Share

  258. SHELTON C, McNeil M, Allen R, Flint L, et al
    Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Mar 9:e0204121. doi: 10.1128/aac.02041.
    >> Share

  259. VAHEDI-SHAHANDASHTI R, Dietl AM, Binder U, Nagl M, et al
    Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?
    Antimicrob Agents Chemother. 2022 Mar 7:e0227421. doi: 10.1128/aac.02274.
    >> Share

  260. SCHARN CR, Tickler IA, Tenover FC, Goering RV, et al
    Characterization of SCCmec Instability in Methicillin-Resistant Staphylococcus aureus Affecting Adjacent Chromosomal Regions, Including the Gene for Staphylococcal Protein A (spa).
    Antimicrob Agents Chemother. 2022 Mar 7:e0237421. doi: 10.1128/aac.02374.
    >> Share

    February 2022
  261. LEE JH, Park YE, Chong YP, Shim TS, et al
    Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
    Antimicrob Agents Chemother. 2022;66:e0152221.
    >> Share

  262. RUEDAS-LOPEZ A, Alonso-Garcia I, Lasarte-Monterrubio C, Guijarro-Sanchez P, et al
    Selection of AmpC beta-Lactamase Variants and Metallo-beta-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections.
    Antimicrob Agents Chemother. 2022;66:e0206721.
    >> Share

  263. SELCHOW P, Ordway DJ, Verma D, Whittel N, et al
    Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0151021.
    >> Share

  264. DAS S, Bush K
    Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria.
    Antimicrob Agents Chemother. 2022;66:e0229921.
    >> Share

  265. TAKAMATSU A, Yaguchi T, Tagashira Y, Watanabe A, et al
    Nocardiosis in Japan: a Multicentric Retrospective Cohort Study.
    Antimicrob Agents Chemother. 2022;66:e0189021.
    >> Share

  266. BIZOT E, Cointe A, Bidet P, Mariani-Kurkdjian P, et al
    Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) Genes.
    Antimicrob Agents Chemother. 2022;66:e0194921.
    >> Share

  267. CHUMBITA M, Puerta-Alcalde P, Gudiol C, Garcia-Pouton N, et al
    Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
    Antimicrob Agents Chemother. 2022;66:e0174421.
    >> Share

    January 2022
  268. BERG A, Clary J, Hanna D, Nuermberger E, et al
    Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database.
    Antimicrob Agents Chemother. 2022 Jan 31:AAC0179321. doi: 10.1128/AAC.01793.
    >> Share

  269. KAYA F, Ernest JP, LoMauro K, Gengenbacher M, et al
    A rabbit model to study antibiotic penetration at the site of infection for non-tuberculous mycobacterial lung disease: macrolide case study.
    Antimicrob Agents Chemother. 2022 Jan 31:aac0221221. doi: 10.1128/aac.02212.
    >> Share

  270. KLINE A, Lionakis MS
    Case Commentary: Long-term fosmanogepix use in a transplant recipient with disseminated aspergillosis caused by azole-resistant Aspergillus calidoustus.
    Antimicrob Agents Chemother. 2022 Jan 24:aac0236821. doi: 10.1128/aac.02368.
    >> Share

  271. DOMENECH P, Mouhoub E, Reed MB
    Experimental confirmation that an uncommon rrs gene mutation (g878a) of Mycobacterium tuberculosis confers resistance to streptomycin.
    Antimicrob Agents Chemother. 2022 Jan 24:AAC0191521. doi: 10.1128/AAC.01915.
    >> Share

  272. KIMURA M, Asano-Mori Y, Sakoh T, Abe M, et al
    Factors associated with breakthrough fungemia caused by Candida, Trichosporon, or Fusarium species when the breakthrough fungemia developed in patients with hematological disorders.
    Antimicrob Agents Chemother. 2022 Jan 18:AAC0208121. doi: 10.1128/AAC.02081.
    >> Share

  273. LEW C, Pellitteri Hahn M, Scarlett C, Rottier A, et al
    Proteomic Correlates of Enhanced Daptomycin Activity Following beta-Lactam Pre-Conditioning in Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2022 Jan 18:AAC0201721. doi: 10.1128/AAC.02017.
    >> Share

  274. BAO X, Bove M, Coenye T
    Organic Acids and Their Salts Potentiate the Activity of Selected Antibiotics against Pseudomonas aeruginosa Biofilms Grown in a Synthetic Cystic Fibrosis Sputum Medium.
    Antimicrob Agents Chemother. 2022;66:e0187521.
    >> Share

  275. CRANE SD, Banerjee SK, Pechous RD
    Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
    Antimicrob Agents Chemother. 2022;66:e0127521.
    >> Share

  276. PHAN JR, Do DM, Truong MC, Ngo C, et al
    An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
    Antimicrob Agents Chemother. 2022;66:e0143521.
    >> Share

  277. WULLNER D, Gesper M, Haupt A, Liang X, et al
    Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics.
    Antimicrob Agents Chemother. 2022;66:e0087821.
    >> Share

  278. MCCONVILLE TH, Austin ED, Geng W, Shi Q, et al
    In Vitro Cytotoxicity and Clinical Correlates of MRSA Bacteremia.
    Antimicrob Agents Chemother. 2022;66:e0155921.
    >> Share

  279. ARAGAW WW, Roubert C, Fontaine E, Lagrange S, et al
    Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
    Antimicrob Agents Chemother. 2022;66:e0140021.
    >> Share

  280. BONNET PL, Le Gal S, Hoffmann CV, Morio F, et al
    Highly Conserved gsc1 Gene of Pneumocystis jirovecii in Patients with or without Prior Exposure to Echinocandins.
    Antimicrob Agents Chemother. 2022;66:e0156321.
    >> Share

  281. ZHENG H, Wang Y, He W, Li F, et al
    In Vitro Activity of Pretomanid against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2022;66:e0181021.
    >> Share

  282. YU R, Chen Z, Schwarz S, Yao H, et al
    Mobilization of tet(X4) by IS1 Family Elements in Porcine Escherichia coli Isolates.
    Antimicrob Agents Chemother. 2022;66:e0159721.
    >> Share

  283. SINDELDECKER D, Prakash S, Stoodley P
    Exploration of the Pharmacodynamics for Pseudomonas aeruginosa Biofilm Eradication by Tobramycin.
    Antimicrob Agents Chemother. 2022;66:e0137121.
    >> Share

  284. EALES BM, Tam VH
    Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection.
    Antimicrob Agents Chemother. 2022;66:e0199621.
    >> Share

  285. ONG V, Wills S, Watson D, Sandison T, et al
    Metabolism, Excretion, and Mass Balance of [(14)C]-Rezafungin in Animals and Humans.
    Antimicrob Agents Chemother. 2022;66:e0139021.
    >> Share

  286. RAO S, Betancourt-Garcia M, Kare-Opaneye YO, Swierczewski BE, et al
    Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy.
    Antimicrob Agents Chemother. 2022;66:e0082421.
    >> Share

  287. NICKLAS DA, Maggioncalda EC, Story-Roller E, Eichelman B, et al
    Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection.
    Antimicrob Agents Chemother. 2022;66:e0170421.
    >> Share

  288. WARRYN L, Pluschke G
    Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Antimicrob Agents Chemother. 2022;66:e0087021.
    >> Share

  289. SCHILDKRAUT JA, Coolen JPM, Burbaud S, Sangen JJN, et al
    RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2022;66:e0150921.
    >> Share

  290. AMBATI S, Pham T, Lewis ZA, Lin X, et al
    DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis.
    Antimicrob Agents Chemother. 2022;66:e0146721.
    >> Share

  291. D'AMICO H, Wallace KL, Burgess D, Burgess DS, et al
    Acute Kidney Injury Associated with Area under the Curve versus Trough Monitoring of Vancomycin in Obese Patients.
    Antimicrob Agents Chemother. 2022;66:e0088621.
    >> Share

  292. KOELE SE, van Beek SW, Maartens G, Brust JCM, et al
    Optimized loading dose strategies for bedaquiline when restarting interrupted drug-resistant tuberculosis treatment.
    Antimicrob Agents Chemother. 2022 Jan 10:AAC0174921. doi: 10.1128/AAC.01749.
    >> Share

  293. KILBURN S, Innes G, Quinn M, Southwick K, et al
    Antifungal Resistance Trends of Candida auris Clinical Isolates, New York-New Jersey, 2016-2020.
    Antimicrob Agents Chemother. 2022 Jan 10:aac0224221. doi: 10.1128/aac.02242.
    >> Share

  294. VU BG, Moye-Rowley WS
    Azole-resistant alleles of ERG11 in Candida glabrata trigger activation of the Pdr1 and Upc2A transcription factors.
    Antimicrob Agents Chemother. 2022 Jan 10:AAC0209821. doi: 10.1128/AAC.02098.
    >> Share

  295. WIRE MB, Jun SY, Jang IJ, Lee SH, et al
    A Phase 1 Study to Evaluate the Safety and Pharmacokinetics following Administration of Single and Multiple Doses of the Anti-Staphylococcal Lysin, LSVT-1701, in Healthy Adult Subjects.
    Antimicrob Agents Chemother. 2022 Jan 10:AAC0184221. doi: 10.1128/AAC.01842.
    >> Share

  296. LONG H, Hu Y, Feng Y, Zong Z, et al
    Genome analysis of Klebsiella oxytoca complex for antimicrobial resistance and virulence genes.
    Antimicrob Agents Chemother. 2022 Jan 10:aac0218321. doi: 10.1128/aac.02183.
    >> Share

  297. SMELTER D, Hayney M, Sakoulas G, Rose W, et al
    Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin 1-beta?
    Antimicrob Agents Chemother. 2022 Jan 3:aac0216621. doi: 10.1128/aac.02166.
    >> Share

    December 2021
  298. NAKANO S, Fujisawa T, Chang B, Ito Y, et al
    Whole-genome analysis-based phylogeographic investigation of Streptococcus pneumoniae serotype 19A sequence type 320 isolates in Japan.
    Antimicrob Agents Chemother. 2021 Dec 20:AAC0139521. doi: 10.1128/AAC.01395.
    >> Share

  299. CAMARGO JF, Jabr R, Anderson AD, Lekakis L, et al
    Successful treatment of disseminated disease due to highly resistant Aspergillus calidoustus with a novel antifungal therapy.
    Antimicrob Agents Chemother. 2021 Dec 20:aac0220621. doi: 10.1128/aac.02206.
    >> Share

  300. TRUONG-BOLDUC QC, Wang Y, Reedy JL, Vyas JM, et al
    Staphylococcus aureus Efflux Pumps and Tolerance to Ciprofloxacin and Chlorhexidine following Induction by Mupirocin.
    Antimicrob Agents Chemother. 2021 Dec 20:AAC0184521. doi: 10.1128/AAC.01845.
    >> Share

  301. CHEN Y, Moran JC, Campbell-Lee S, Horsburgh MJ, et al
    Transcriptomic responses and survival mechanisms of staphylococci to the antimicrobial skin lipid sphingosine.
    Antimicrob Agents Chemother. 2021 Dec 13:AAC0056921. doi: 10.1128/AAC.00569.
    >> Share

  302. LACKNER N, Vahedi-Shahandashti R, Jahnig S, Schonherr L, et al
    Echinocandins and their Activity against Aspergillus terreus Species Complex: A Novel Agar Screening Method.
    Antimicrob Agents Chemother. 2021 Dec 13:AAC0190921. doi: 10.1128/AAC.01909.
    >> Share

  303. HUANG J, Guo S, Li X, Yuan F, et al
    Nemonoxacin enhances antibacterial activity and anti-resistant mutation ability of vancomycin against methicillin-resistant Staphylococcus aureus in an in vitro dynamic pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2021 Dec 13:AAC0180021. doi: 10.1128/AAC.01800.
    >> Share

  304. AGUIAR-ALVES F, Le HN, Tran VG, Gras E, et al
    Anti-virulence Bispecific Monoclonal Antibody Mediated Protection Against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model.
    Antimicrob Agents Chemother. 2021 Dec 13:AAC0202221. doi: 10.1128/AAC.02022.
    >> Share

  305. LYONS MA
    Pharmacodynamics and the Bactericidal Activity of Bedaquiline in Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Dec 6:AAC0163621. doi: 10.1128/AAC.01636.
    >> Share

  306. KIM JS, Kim YH, Lee SH, Kim YH, et al
    Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Dec 6:AAC0168421. doi: 10.1128/AAC.01684.
    >> Share

  307. KHALIFA HO, Hubka V, Watanabe A, Nagi M, et al
    Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candida krusei recovered from an International Collection.
    Antimicrob Agents Chemother. 2021 Dec 6:AAC0185621. doi: 10.1128/AAC.01856.
    >> Share

  308. VERMA R, Gurumurthy M, Yeo BCM, Lu Q, et al
    Effects of increasing concentrations of rifampicin on different Mycobacterium tuberculosis lineages in a Whole blood Bactericidal Activity Assay.
    Antimicrob Agents Chemother. 2021 Dec 6:AAC0169921. doi: 10.1128/AAC.01699.
    >> Share

    November 2021
  309. POON R, Basuino L, Satishkumar N, Chatterjee A, et al
    Loss of GdpP function in Staphylococcus aureus leads to beta-lactam tolerance and enhanced evolution of beta-lactam resistance.
    Antimicrob Agents Chemother. 2021 Nov 29:AAC0143121. doi: 10.1128/AAC.01431.
    >> Share

  310. SASAKI T, Svensson EM, Wang X, Wang Y, et al
    Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2021 Nov 29:AAC0160821. doi: 10.1128/AAC.01608.
    >> Share

  311. CARVALHAES CG, Sader HS, Streit JM, Castanheira M, et al
    Activity of Oritavancin Against Gram-positive Pathogens Causing Bloodstream Infections in the United States Over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0166721. doi: 10.1128/AAC.01667.
    >> Share

  312. VOGENSEN VB, Bolhuis MS, Sturkenboom MGG, van der Werf TS, et al
    Clinical relevance of rifampicin-moxifloxacin interaction in isoniazid resistant/intolerant tuberculosis patients.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0182921. doi: 10.1128/AAC.01829.
    >> Share

  313. WEI J, Tong K, Wang H, Wen Y, et al
    Intra-articular vancomycin for the prophylaxis of periprosthetic joint infection caused by methicillin-resistant S. aureus after total knee arthroplasty in a rat model: the dosage, efficacy, and safety.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0164121. doi: 10.1128/AAC.01641.
    >> Share

  314. LEE YL, Ko WC, Hsueh PR
    Geographic Patterns of Carbapenem-resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2015-2019.
    Antimicrob Agents Chemother. 2021 Nov 22:AAC0200021. doi: 10.1128/AAC.02000.
    >> Share

  315. CRANDON JL, Kuti JL, Nicolau DP
    Erratum for Crandon et al., "Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model".
    Antimicrob Agents Chemother. 2021;65:e0187821.
    >> Share

  316. REITZEL RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, et al
    Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms".
    Antimicrob Agents Chemother. 2021;65:e0198621.
    >> Share

  317. NEWMAN LM, Kankam M, Nakamura A, Conrad T, et al
    Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
    Antimicrob Agents Chemother. 2021;65:e0129221.
    >> Share

  318. JOUSSET AB, Oueslati S, Emeraud C, Bonnin RA, et al
    KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate.
    Antimicrob Agents Chemother. 2021;65:e0116021.
    >> Share

  319. FIGUEIREDO ABC, Fonseca FL, Kuczera D, Conte FP, et al
    Monoclonal Antibodies against Cell Wall Chitooligomers as Accessory Tools for the Control of Cryptococcosis.
    Antimicrob Agents Chemother. 2021;65:e0118121.
    >> Share

  320. KERKEZ I, Tulkens PM, Tenson T, Van Bambeke F, et al
    Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an In Vitro Model of Intracellular Infection.
    Antimicrob Agents Chemother. 2021;65:e0146821.
    >> Share

  321. MUHLEN S, Zapol'skii VA, Bilitewski U, Dersch P, et al
    Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.
    Antimicrob Agents Chemother. 2021;65:e0095821.
    >> Share

  322. VANSCOY BD, Lakota EA, Conde H, Fikes S, et al
    Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems.
    Antimicrob Agents Chemother. 2021;65:e0012221.
    >> Share

  323. PEYRUSSON F, Whelan AO, Hartley MG, Norville IH, et al
    Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.
    Antimicrob Agents Chemother. 2021;65:e0106121.
    >> Share

  324. KELLY MC, Yeager SD, Shorman MA, Wright LR, et al
    Incidence and Predictors of Gram-Negative Bacilli in Hospitalized People Who Inject Drugs with Injection Drug Use-Attributable Infections.
    Antimicrob Agents Chemother. 2021;65:e0092521.
    >> Share

  325. SORAYAH R, Moraski GC, Barkan D, Pethe K, et al
    The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021;65:e0096421.
    >> Share

  326. MARTINS O, Lee J, Kaushik A, Ammerman NC, et al
    In Vitro Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021;65:e0154521.
    >> Share

  327. LI D, Sabato PE, Guiastrennec B, Ouerdani A, et al
    Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infections.
    Antimicrob Agents Chemother. 2021;65:e0089521.
    >> Share

  328. SINGULANI JL, Oliveira LT, Ramos MD, Fregonezi NF, et al
    The Antimicrobial Peptide MK58911-NH2 Acts on Planktonic, Biofilm, and Intramacrophage Cells of Cryptococcus neoformans.
    Antimicrob Agents Chemother. 2021;65:e0090421.
    >> Share

  329. SHARMA D, Paul RA, Rudramurthy SM, Kashyap N, et al
    Impact of FKS1 genotype on echinocandin in-vitro susceptibility in Candida auris and in-vivo response in a murine model of infection.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0165221. doi: 10.1128/AAC.01652.
    >> Share

  330. NIIMI M, Niimi K, Tanabe K, Cannon RD, et al
    Inhibitor Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0174821. doi: 10.1128/AAC.01748.
    >> Share

  331. YAMAMURO R, Kimura M, Asano-Mori Y, Abe M, et al
    Clinical and microbiological characteristics of proven invasive aspergillosis due to rare/cryptic species in allogeneic hematopoietic stem cell transplant recipients.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0163021. doi: 10.1128/AAC.01630.
    >> Share

  332. YU JF, Xu JT, Yang SS, Gao MN, et al
    Decreased methylenetetrahydrofolate reductase activity leads to increased sensitivity to para-aminosalicylic acid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0146521. doi: 10.1128/AAC.01465.
    >> Share

  333. RIVAS L, Alcalde-Rico M, Martinez JR, Moreno V, et al
    Real-world Performance of Susceptibility Testing for Ceftolozane/Tazobactam Against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0165721. doi: 10.1128/AAC.01657.
    >> Share

  334. PHAN MD, Peters KM, Alvarez Fraga L, Wallis SC, et al
    Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0214621. doi: 10.1128/AAC.02146.
    >> Share

  335. LIAO YS, Chen BH, Teng RH, Wang YW, et al
    Antimicrobial resistance in Campylobacter coli and Campylobacter jejuni from human campylobacteriosis in Taiwan, 2016-2019.
    Antimicrob Agents Chemother. 2021 Nov 8:AAC0173621. doi: 10.1128/AAC.01736.
    >> Share

  336. MORRISETTE T, Lev KL, Canfield GS, Duerkop BA, et al
    Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin Against Daptomycin-Nonsusceptible Enterococcus faecium.
    Antimicrob Agents Chemother. 2021 Nov 1:AAC0162321. doi: 10.1128/AAC.01623.
    >> Share

  337. KARAU MJ, Schmidt-Malan SM, Cunningham SA, Mandrekar JN, et al
    Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Nov 1:AAC0170321. doi: 10.1128/AAC.01703.
    >> Share

    October 2021
  338. HERREN SC, Huemer M, Acevedo CT, Gomez-Mejia A, et al
    Assessing antibiotic tolerance of Staphylococcus aureus derived directly from patients by the Replica Plating Tolerance Isolation System - REPTIS.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0096721. doi: 10.1128/AAC.00967.
    >> Share

  339. ANAHTAR MN, Bramante JT, Xu J, Desrosiers LA, et al
    Prediction of antimicrobial resistance in clinical Enterococcus faecium isolates using a rules-based analysis of whole genome sequences.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0119621. doi: 10.1128/AAC.01196.
    >> Share

  340. BUTCHER MC, Brown JL, Hansom D, Wilson-Van Os R, et al
    Antifungal loaded calcium sulfate beads as a potential therapeutic in combating Candida auris.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0171321. doi: 10.1128/AAC.01713.
    >> Share

  341. MISHRA NN, Lew C, Abdelhady W, Lapitan CK, et al
    Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant S. aureus: In vitro, Ex vivo and In vivo Metrics.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164921. doi: 10.1128/AAC.01649.
    >> Share

  342. DEMCZUK W, Martin I, Griffith A, Lefebvre B, et al
    Linear regression equations to predict beta-lactam, macrolide, lincosamide and fluoroquinolone minimum inhibitory concentrations from molecular antimicrobial resistance determinants in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0137021. doi: 10.1128/AAC.01370.
    >> Share

  343. BAKLOUTI S, Marolleau S, Chavanet P, Bonnet E, et al
    Letter to the Editor on: "Population Pharmacokinetics of Dalbavancin and Dosing Considerations for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections".
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0149321. doi: 10.1128/AAC.01493.
    >> Share

  344. CAFLISCH KM, Patel R
    Phage Activity Against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection Isolates.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0187921. doi: 10.1128/AAC.01879.
    >> Share

  345. JIANG S, Zhuang H, Zhu F, Wei X, et al
    The role of mprF mutations in "see-saw effect" of Daptomycin-resistant methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2021 Oct 18:AAC0129521. doi: 10.1128/AAC.01295.
    >> Share

  346. BAGHDADI JD, Coffey KC, Adediran T, Goodman KE, et al
    Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Antimicrob Agents Chemother. 2021;65:e0134121.
    >> Share

  347. SHORTRIDGE D, Arends SJR, Streit JM, Castanheira M, et al
    Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65:e0126421.
    >> Share

  348. TALLEY AK, Thurston A, Moore G, Gupta VK, et al
    First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections.
    Antimicrob Agents Chemother. 2021;65:e0120821.
    >> Share

  349. FONTANA H, Cardoso B, Esposito F, de Lima AV, et al
    Small IncQ1 Plasmid Encoding KPC-2 Expands to Invasive Nontyphoidal Salmonella.
    Antimicrob Agents Chemother. 2021;65:e0155221.
    >> Share

  350. GUO Q, Xu L, Tan F, Zhang Y, et al
    A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro.
    Antimicrob Agents Chemother. 2021;65:e0088921.
    >> Share

  351. KOMM O, Almeida DV, Converse PJ, Omansen TF, et al
    Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer.
    Antimicrob Agents Chemother. 2021;65:e0141821.
    >> Share

  352. BANERJEE R, Cunningham SA, Beisken S, Posch AE, et al
    Core Genome Multilocus Sequence Typing and Prediction of Antimicrobial Susceptibility Using Whole-Genome Sequences of Escherichia coli Bloodstream Infection Isolates.
    Antimicrob Agents Chemother. 2021;65:e0113921.
    >> Share

  353. RUBINO CM, Flanagan S
    Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections.
    Antimicrob Agents Chemother. 2021;65:e0084221.
    >> Share

  354. LOVEY A, Krel M, Borchardt A, Brady T, et al
    Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2021;65:e0098521.
    >> Share

  355. STOTT KE, Le T, Nguyen T, Whalley S, et al
    Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei.
    Antimicrob Agents Chemother. 2021;65:e0063621.
    >> Share

  356. CLAY KA, Hartley MG, Armstrong S, Bewley KR, et al
    Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever.
    Antimicrob Agents Chemother. 2021;65:e0067321.
    >> Share

  357. ZAIDAN N, Hornak JP, Reynoso D
    Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.
    Antimicrob Agents Chemother. 2021;65:e0092421.
    >> Share

  358. CUBRIA MB, Vega LA, Shropshire WC, Sanson MA, et al
    Population genomics reveals distinct temporal association with the emergence of ST1 serotype V Group B Streptococcus and macrolide resistance in North America.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0071421. doi: 10.1128/AAC.00714.
    >> Share

  359. WILLIAMSON B, Wilk A, Guerrero KD, Mikulski TD, et al
    Impact of Erg11 amino acid substitutions identified in Candida auris clade III isolates on triazole drug susceptibility.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0162421. doi: 10.1128/AAC.01624.
    >> Share

  360. EVERT BJ, Slesarenko VA, Punnasseril JMJ, Taha, et al
    Self-inhibitory peptides targeting the Neisseria gonorrhoeae MtrCDE efflux pump increase antibiotic susceptibility.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0154221. doi: 10.1128/AAC.01542.
    >> Share

  361. GANAPATHY US, Del Rio RG, Cacho-Izquierdo M, Ortega F, et al
    A Mycobacterium tuberculosis NBTI DNA gyrase inhibitor is active against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0151421. doi: 10.1128/AAC.01514.
    >> Share

  362. JACQUELINE C, Caillon J, Meyer O, Dailly E, et al
    Efficacy of Nano-Encapsulated Daptomycin in an Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Bone and Joint Infection Model.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0076821. doi: 10.1128/AAC.00768.
    >> Share

  363. RADTKE KK, Ernest JP, Zhang N, Ammerman NC, et al
    Comparative efficacy of rifapentine alone and in combination with isoniazid for latent tuberculosis infection: a translational pharmacokinetic-pharmacodynamic modelling study.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0170521. doi: 10.1128/AAC.01705.
    >> Share

  364. IKEDA T, Suzuki R, Jin W, Wachino JI, et al
    Isolation of Group A Streptococci with Reduced In Vitro beta-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.
    Antimicrob Agents Chemother. 2021 Oct 4:AAC0148221. doi: 10.1128/AAC.01482.
    >> Share

    September 2021
  365. DIAZ-GARCIA J, Mesquida A, Gomez A, Machado M, et al
    Antifungal susceptibility testing identifies the abdominal cavity as a source of Candida glabrata resistant isolates.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0124921. doi: 10.1128/AAC.01249.
    >> Share

  366. ALMEIDA D, Converse PJ, Li SY, Upton AM, et al
    Comparative efficacy of the novel diarylquinoline TBAJ-876 and bedaquiline against a resistant Rv0678 mutant in a mouse model of tuberculosis.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0141221. doi: 10.1128/AAC.01412.
    >> Share

  367. INGLE DJ, Andersson P, Valcanis M, Wilmot M, et al
    Genomic epidemiology and antimicrobial resistance mechanisms of imported typhoid in Australia.
    Antimicrob Agents Chemother. 2021 Sep 20:AAC0120021. doi: 10.1128/AAC.01200.
    >> Share

    August 2021
  368. HOWARD-ANDERSON J, van Duin D
    Uncertainty in evaluating treatment outcomes in carbapenem-resistant Acinetobacter baumannii infections.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0142421. doi: 10.1128/AAC.01424.
    >> Share

  369. MUKHERJEE S, Blankenship HM, Rodrigues JA, Mosci RE, et al
    Antibiotic susceptibility profiles and frequency of resistance genes in clinical Shiga toxin-producing Escherichia coli isolates from Michigan over a 14-year period.
    Antimicrob Agents Chemother. 2021 Aug 23:AAC0118921. doi: 10.1128/AAC.01189.
    >> Share

  370. GILL CM, Aktathorn E, Alfouzan W, Bourassa L, et al
    Elevated MICs of Susceptible Anti-Pseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.
    Antimicrob Agents Chemother. 2021 Aug 16:AAC0120421. doi: 10.1128/AAC.01204.
    >> Share

  371. NGWALERO P, Brust JCM, van Beek SW, Wasserman S, et al
    Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0239920. doi: 10.1128/AAC.02399.
    >> Share

  372. GUTIERREZ-GUTIERREZ B, Perez-Nadales E, Perez-Galera S, Fernandez-Ruiz M, et al
    Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing Enterobacterales in kidney transplant recipients: a propensity score and DOOR-based analysis.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0110221. doi: 10.1128/AAC.01102.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016